SERELYS FERTI HOMME
Food supplement declared in France, decision dated 14 May 2025
SERELYS FERTI HOMME, from UPSA SAS, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: pollen 320 mg per day, Vitamin E, Zinc. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- SERELYS
- Food business operator placing the product on the market
- UPSA SAS
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 1 gélule
- Directions for use
- 1 gélule par jour le matin ou le soir.
- Intended populations
- Men
- Not recommended (according to the manufacturer)
- Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year)
- Objectives stated by the manufacturer (these are not authorised claims)
- Autre : Fertilité masculine
Declaration 260287, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Substances
| Name | Per day |
|---|---|
| pollen | 320 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-alpha-tocopheryl acetate | Vitamin E | 300 mg | 30 mg |
| zinc gluconate | Zinc | 25 mg | 15 mg |
Additives
E470b, E460
Other ingredients
fécule de pomme de terre
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Ce produit n’est pas destiné aux femmes enceintes ni aux enfants. Tenir hors de portée des jeunes enfants. En cas d’allergie connue au pollen, demandez conseil à votre pharmacien ou médecin.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Sérélys FERTI homme FCL SCIENCE B.V., declared in 2023 : different composition: 1 ingredient(s) added, 0 missing
- Sérélys FERTI homme FCL SCIENCE B.V., declared in 2022, earlier declaration, replaced by the 2023 declaration : different composition: 3 ingredient(s) added, 1 missing
Brand : SERELYS
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “SERELYS FERTI HOMME: composition and regulation”, https://compoatlas.com/en/supplements/products/260287-serelys-ferti-homme, updated 15 November 2026.